5α-Reductase Inhibition Coupled With Short Off Cycles Increases Survival in the LNCaP Xenograft Prostate Tumor Model on Intermittent Androgen Deprivation Therapy
Journal of Urology - Netherlands
doi 10.1016/j.juro.2014.10.101
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2015
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)